Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson's Disease

被引:2
作者
Shinko, Aiko [1 ]
Agari, Takashi [1 ]
Kameda, Masahiro [1 ]
Yasuhara, Takao [1 ]
Kondo, Akihiko [1 ]
Tayra, Judith Thomas [1 ]
Sato, Kenichiro [1 ]
Sasaki, Tatsuya [1 ]
Sasada, Susumu [1 ]
Takeuchi, Hayato [1 ]
Wakamori, Takaaki [1 ]
Borlongan, Cesario V. [2 ]
Date, Isao [1 ]
机构
[1] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan
[2] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA
来源
PLOS ONE | 2014年 / 9卷 / 07期
基金
日本学术振兴会;
关键词
ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DORSAL COLUMN STIMULATION; ELECTRICAL-STIMULATION; SUBARACHNOID HEMORRHAGE; DOPAMINERGIC-NEURONS; RAT MODEL; IN-VITRO; PAIN;
D O I
10.1371/journal.pone.0101468
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In clinical practice, deep brain stimulation (DBS) is effective for treatment of motor symptoms in Parkinson's disease (PD). However, the mechanisms have not been understood completely. There are some reports that electrical stimulation exerts neuroprotective effects on the central nervous system diseases including cerebral ischemia, head trauma, epilepsy and PD, although there are a few reports on neuroprotective effects of spinal cord stimulation (SCS). We investigated the neuroprotective effects of high cervical SCS on PD model of rats. Adult female Sprague-Dawley rats received hour-long SCS (2, 50 or 200 Hz) with an epidural electrode at C1-2 level for 16 consecutive days. At 2 days after initial SCS, 6-hydroxydopamine (6-OHDA) was injected into the right striatum of rats. Behavioral evaluations of PD symptoms were employed, including cylinder test and amphetamine-induced rotation test performed at 1 and 2 weeks after 6-OHDA injection. Animals were subsequently euthanized for immunohistochemical investigations. In order to explore neurotrophic and growth factor upregulation induced by SCS, another cohort of rats that received 50 Hz SCS was euthanized at 1 and 2 weeks after lesion for protein assays. Behavioral tests revealed that the number of amphetamine-induced rotations decreased in SCS groups. Immunohistochemically, tyrosine hydroxylase (TH)-positive fibers in the striatum were significantly preserved in SCS groups. TH-positive neurons in the substantia nigra pars compacta were significantly preserved in 50 Hz SCS group. The level of vascular endothelial growth factor (VEGF) was upregulated by SCS at 1 week after the lesion. These results suggest that high cervical SCS exerts neuroprotection in PD model of rats, at least partially by upregulation of VEGF. SCS is supposed to suppress or delay PD progression and might become a less invasive option for PD patients, although further preclinical and clinical investigations are needed to confirm the effectiveness and safety.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report
    Akiyama, Hisanao
    Nukui, Saki
    Akamatu, Masashi
    Hasegawa, Yasuhiro
    Nishikido, Osamu
    Inoue, Soichiro
    BMC NEUROLOGY, 2017, 17
  • [22] Neuroprotective effects of astaxanthin in a rat model of spinal cord injury
    Masoudi, Alireza
    Dargahi, Leila
    Abbaszadeh, Fatemeh
    Pourgholami, Mohammad Hosein
    Asgari, Alireza
    Manoochehri, Mehdi
    Jorjani, Masoumeh
    BEHAVIOURAL BRAIN RESEARCH, 2017, 329 : 104 - 110
  • [23] Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review
    dos Santos, Michele Goulart
    Schimith, Lucia Emanueli
    Andre-Miral, Corinne
    Muccillo-Baisch, Ana Luiza
    Arbo, Bruno Dutra
    Hort, Mariana Appel
    NEUROTOXICITY RESEARCH, 2022, 40 (01) : 319 - 345
  • [24] Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model
    Li, Yanwei
    Liu, WeiZhen
    Li, Lin
    Hoelscher, Christian
    NEUROPHARMACOLOGY, 2016, 101 : 255 - 263
  • [25] PPARs and Their Neuroprotective Effects in Parkinson's Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
    Perez-Segura, Isaac
    Santiago-Balmaseda, Alberto
    Rodriguez-Hernandez, Luis Daniel
    Morales-Martinez, Adriana
    Martinez-Becerril, Hilda Angelica
    Martinez-Gomez, Paola A. A.
    Delgado-Minjares, Karen M. M.
    Salinas-Lara, Citlaltepetl
    Martinez-Davila, Irma A. A.
    Guerra-Crespo, Magdalena
    Perez-Severiano, Francisca
    Soto-Rojas, Luis O. O.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [26] Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives
    Sarkar, Sumit
    Raymick, James
    Imam, Syed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06)
  • [27] Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson?s disease: GPER as a potential target
    Zhang, Mei
    Hu, Zi-Fan
    Dong, Xiao-Li
    Chen, Wen-Fang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [28] Neuroprotective effects of tanshinone IIA in experimental model of Parkinson disease in rats
    Zhang, Li
    Li, Qiangzi
    ARABIAN JOURNAL OF CHEMISTRY, 2022, 15 (11)
  • [29] Neuroprotective effects of Shende'an tablet in the Parkinson's disease model
    Sheng, Xiaoyan
    Yang, Shuiyuan
    Wen, Xiaomin
    Zhang, Xin
    Ye, Yongfeng
    Zhao, Peng
    Zang, Limin
    Peng, Kang
    Du, Enming
    Li, Sai
    CHINESE MEDICINE, 2021, 16 (01)
  • [30] Neuroprotective effects of microRNA 124 in Parkinson's disease mice
    Zhang, Fubo
    Yao, Yufang
    Miao, Na
    Wang, Nan
    Xu, Xin
    Yang, Chaoping
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2022, 99